ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Mississippi » Hematology Oncology

Top Hematology Oncology Prescribers in Mississippi

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JULIAN HILL MD

Hematology Oncology

7,913

$961K

778
590 are 65+

18%
patients receiving schedule two controlled substances

Avg: 16%

20%
patients receiving schedule three controlled substances

Avg: 22%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 17%

$121
Average prescription price

Avg: $375

TAMMY YOUNG M.D.

Hematology Oncology

4,476

$891K

460
361 are 65+

13%
patients receiving schedule two controlled substances

Avg: 16%

23%
patients receiving schedule three controlled substances

Avg: 22%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 17%

$199
Average prescription price

Avg: $375

ANDREW KELLUM MD

Hematology Oncology

4,174

$1.15M

447
323 are 65+

15%
patients receiving schedule two controlled substances

Avg: 16%

19%
patients receiving schedule three controlled substances

Avg: 22%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 17%

$275
Average prescription price

Avg: $375

NAGENDRANATH BELLARE MD

Hematology Oncology

3,709

$1.63M

305
235 are 65+

10%
patients receiving schedule two controlled substances

Avg: 16%

16%
patients receiving schedule three controlled substances

Avg: 22%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 17%

$439
Average prescription price

Avg: $375

CHARLES MONTGOMERY MD

Hematology Oncology

3,479

$862K

454
343 are 65+

14%
patients receiving schedule two controlled substances

Avg: 16%

24%
patients receiving schedule three controlled substances

Avg: 22%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 17%

$248
Average prescription price

Avg: $375

CHRISTOPHER CROOT MD

Hematology Oncology

3,004

$2M

388
269 are 65+

24%
patients receiving schedule two controlled substances

Avg: 16%

20%
patients receiving schedule three controlled substances

Avg: 22%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 17%

$665
Average prescription price

Avg: $375

GRACE SHUMAKER M.D.

Hematology Oncology

2,856

$1.59M

326
260 are 65+

14%
patients receiving schedule two controlled substances

Avg: 16%

14%
patients receiving schedule three controlled substances

Avg: 22%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 17%

$558
Average prescription price

Avg: $375

BOB WILKERSON M.D.

Hematology Oncology

2,849

$1.44M

333
256 are 65+

26%
patients receiving schedule two controlled substances

Avg: 16%

31%
patients receiving schedule three controlled substances

Avg: 22%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 17%

$504
Average prescription price

Avg: $375

LISA BOND MD

Hematology Oncology

2,839

$912K

305
218 are 65+

14%
patients receiving schedule two controlled substances

Avg: 16%

13%
patients receiving schedule three controlled substances

Avg: 22%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 17%

$321
Average prescription price

Avg: $375

BOBBY GRAHAM M.D.

Hematology Oncology

2,509

$725K

335
289 are 65+

20%
patients receiving schedule two controlled substances

Avg: 16%

22%
patients receiving schedule three controlled substances

Avg: 22%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 17%

$289
Average prescription price

Avg: $375

SONIA BENN MD

Hematology Oncology

2,234

$774K

221
153 are 65+

22%
patients receiving schedule two controlled substances

Avg: 16%

21%
patients receiving schedule three controlled substances

Avg: 22%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 17%

$346
Average prescription price

Avg: $375

NICOLE CLEVELAND MD

Hematology Oncology

2,139

$615K

264
194 are 65+

18%
patients receiving schedule two controlled substances

Avg: 16%

25%
patients receiving schedule three controlled substances

Avg: 22%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 17%

$288
Average prescription price

Avg: $375

MAROUN HAYEK MD

Hematology Oncology

1,981

$1.37M

224
165 are 65+

7%
patients receiving schedule two controlled substances

Avg: 16%

25%
patients receiving schedule three controlled substances

Avg: 22%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 17%

$692
Average prescription price

Avg: $375

ALLISON WALL M.D.

Hematology Oncology

1,870

$443K

161
112 are 65+

18%
patients receiving schedule two controlled substances

Avg: 16%

25%
patients receiving schedule three controlled substances

Avg: 22%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 17%

$237
Average prescription price

Avg: $375

JUSTIN BAKER M.D.

Hematology Oncology

1,811

$594K

306
233 are 65+

22%
patients receiving schedule two controlled substances

Avg: 16%

23%
patients receiving schedule three controlled substances

Avg: 22%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 17%

$328
Average prescription price

Avg: $375

GUANGZHI QU M.D.

Hematology Oncology

1,756

$1.35M

277
202 are 65+

16%
patients receiving schedule two controlled substances

Avg: 16%

29%
patients receiving schedule three controlled substances

Avg: 22%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 17%

$771
Average prescription price

Avg: $375

MANUBHAI PATEL M.D.

Hematology Oncology

1,743

$653K

238
187 are 65+

19%
patients receiving schedule two controlled substances

Avg: 16%

30%
patients receiving schedule three controlled substances

Avg: 22%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 17%

$375
Average prescription price

Avg: $375

JOHN HROM MD

Hematology Oncology

1,720

$550K

187
134 are 65+

30%
patients receiving schedule two controlled substances

Avg: 16%

41%
patients receiving schedule three controlled substances

Avg: 22%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 17%

$320
Average prescription price

Avg: $375

JACK RODRIGUEZ MD

Hematology Oncology

1,712

$869K

224
175 are 65+

10%
patients receiving schedule two controlled substances

Avg: 16%

18%
patients receiving schedule three controlled substances

Avg: 22%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 17%

$508
Average prescription price

Avg: $375

MARTIN NEWCOMB M.D.

Hematology Oncology

1,678

$1.59M

206
155 are 65+

10%
patients receiving schedule two controlled substances

Avg: 16%

18%
patients receiving schedule three controlled substances

Avg: 22%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 17%

$949
Average prescription price

Avg: $375

WAIL ALNAS MD

Hematology Oncology

1,607

$535K

168
128 are 65+

14%
patients receiving schedule two controlled substances

Avg: 16%

23%
patients receiving schedule three controlled substances

Avg: 22%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 17%

$333
Average prescription price

Avg: $375

PURUSHOTTAM PANDE MD

Hematology Oncology

1,420

$307K

184
124 are 65+

16%
patients receiving schedule two controlled substances

Avg: 16%

24%
patients receiving schedule three controlled substances

Avg: 22%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 17%

$216
Average prescription price

Avg: $375

BENTON WHEELER MD

Hematology Oncology

1,399

$647K

201
135 are 65+

9%
patients receiving schedule two controlled substances

Avg: 16%

14%
patients receiving schedule three controlled substances

Avg: 22%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 17%

$462
Average prescription price

Avg: $375

SHANNON PENLAND MD

Hematology Oncology

1,327

$693K

210
161 are 65+

14%
patients receiving schedule two controlled substances

Avg: 16%

22%
patients receiving schedule three controlled substances

Avg: 22%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 17%

$522
Average prescription price

Avg: $375

DAVID SULLIVAN M.D.

Hematology Oncology

1,322

$264K

185
131 are 65+

17%
patients receiving schedule two controlled substances

Avg: 16%

27%
patients receiving schedule three controlled substances

Avg: 22%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 17%

$200
Average prescription price

Avg: $375

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank